Valiant Laboratories Ltd
Fri 4/07/2025,15:44:55 | NSE : VALIANTLAB
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 117.95
Previous Close
₹ 114.55
Volume
32184
Mkt Cap ( Rs. Cr)
₹507.84
High
₹ 120.21
Low
₹ 115.05
52 Week High
₹ 157.49
52 Week Low
₹ 75.20
Book Value Per Share
₹ 53.31
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Valiant Laboratories Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Valiant Laboratories Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Valiant Laboratories - Clarification - Financial Results
-
Valiant Laboratories - Trading Window-XBRL
-
Valiant Laboratories - Trading Window
-
Valiant Laboratories - Credit Rating
-
Valiant Laboratories - Announcement under Regulation 30 (LODR)-Credit Rating
-
Valiant Laboratories - Disclosure under SEBI Takeover Regulations
-
Valiant Laboratories - Outcome of Board Meeting
-
Valiant Laboratories - Copy of Newspaper Publication
-
Valiant Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
-
Valiant Laboratories - Resignation
-
Valiant Laboratories - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Valiant Laboratories - Outcome of Board Meeting
-
Valiant Laboratories - Financial Results For The Quarter And Year Ended March 31, 2025
-
Valiant Laboratories posts Q4 net profit of Rs 3.24 cr
-
Valiant Laboratories - Outcome of Board Meeting
-
Valiant Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Dated May 20, 2025.
-
Valiant Laboratories - Board Meeting Intimation
-
Valiant Laboratories - Board Meeting Intimation for Board Meeting Intimation For Considering And Approving Audited Standalone
-
Valiant Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Valiant Laboratories - Disclosure under SEBI Takeover Regulations
-
Valiant Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Valiant Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Valiant Laboratories Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | |
|---|---|---|---|---|---|
| Assets | 293.7833 | 296.2821 | 159.89 | 132.141 | |
| Liabilities | 293.7833 | 296.2821 | 159.89 | 132.141 | |
| Equity | 43.45 | 43.45 | 32.56 | 16.28 | |
| Gross Profit | -4.676 | -8.4083 | 35.09 | 42.318 | |
| Net Profit | -2.1502 | 0.3403 | 28.998 | 27.496 | |
| Cash From Operating Activities | -21.9012 | 48.7819 | 22.956 | 2.251 | |
| NPM(%) | -1.61 | 0.18 | 8.68 | 9.43 | |
| Revenue | 133.3618 | 182.0525 | 333.91 | 291.523 | |
| Expenses | 138.0378 | 190.4608 | 298.82 | 249.205 | |
| ROE(%) | -0.92 | 0.14 | 12.52 | 11.87 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Valiant Laboratories Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 946.55 | 6.41 | 31.41 | 66.17 | 301.39 | 0.53 |
| Lotus Eye Hospital and Institute Ltd | 71.87 | 0.63 | 205.34 | 241.13 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 11.43 | -0.17 | 190.50 | 124.29 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 945.00 | 0.49 | 0.00 | 227.37 | -601.21 | 0.00 |
Company Info
The Company was originally formed as a partnership firm under Indian Partnership Act, 1932, under the name and style of "M/s Bharat Chemicals" pursuant to the deed of partnership dated October 17, 1980. Subsequently, the partnership firm, M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name "Valiant Laboratories Limited" pursuant to certificate of incorporation dated August 16, 2021 issued by Central Registration Centre, Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area, Palghar, Maharashtra on leasehold basis admeasuring about 1,000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28, L-28 (part), L-29 and L-13 at Tarapur Industrial Area, Palghar, Maharashtra collectively admeasuring about 3,000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1,000 million2022- The annual revenue from operations crossed Rs.2,000 million- Formed the wholly owned subsidiary, VASPL to diversify the business activities
The Company was originally formed as a partnership firm under Indian Partnership Act, 1932, under the name and style of "M/s Bharat Chemicals" pursuant to the deed of partnership dated October 17, 1980. Subsequently, the partnership firm, M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name "Valiant Laboratories Limited" pursuant to certificate of incorporation dated August 16, 2021 issued by Central Registration Centre, Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area, Palghar, Maharashtra on leasehold basis admeasuring about 1,000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28, L-28 (part), L-29 and L-13 at Tarapur Industrial Area, Palghar, Maharashtra collectively admeasuring about 3,000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1,000 million2022- The annual revenue from operations crossed Rs.2,000 million- Formed the wholly owned subsidiary, VASPL to diversify the business activities
Read More
Parent Organisation
Valiant Laboratories Ltd.
Founded
06/08/2021
Managing Director
Mr.Santosh S Vora
NSE Symbol
VALIANTLABEQ
FAQ
The current price of Valiant Laboratories Ltd is ₹ 116.88.
The 52-week high for Valiant Laboratories Ltd is ₹ 120.21 and the 52-week low is ₹ 115.05.
The market capitalization of Valiant Laboratories Ltd is currently ₹ 507.84. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Valiant Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Valiant Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Valiant Laboratories Ltd shares.
The CEO of Valiant Laboratories Ltd is Mr.Santosh S Vora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
